Drug consumption rooms and needle and syringe exchange programs have existed in some shape or form in different parts of the world for many years now. This Research Note reviews some of their advantages and disadvantages and considers possible advancements.
Get full access to this article
View all access options for this article.
References
1.
BastosF. I.StrathdeeS. A.2000Evaluating effectiveness of syringe exchange programs: Current issues and future prospects. Social Science and Medicine, 51 (12), 1771–1782.
2.
BraineN.Des JarlaisD.GoldblattC.2004Long-term effects of syringe exchange on risk behavior and HIV prevention. AIDS Education and Prevention, 16 (3), 264–275.
3.
BruneauJ.LamotheF.FrancoE.1997High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology, 146 (12), 994–1002.
4.
CarlsonR. G.2000Shooting galleries, dope houses, and injection doctors: Examining the social ecology of HIV risk behaviors among drug injectors in Dayton, Ohio. Human Organ, 59 (3), 325.
5.
Centers for Disease Control and Prevention2005Basic statistics: AIDS cases by exposure category. Atlanta, GA: CDC.
6.
Centers for Disease Control and Prevention2002Drug-associated HIV transmission continues in the United States. Atlanta, GA: CDC.
7.
City of Vancouver Four Pillars Drug Strategy2003Supervised injection sites (SISs): Frequently asked questions. City of Vancouver.
8.
De JongW.WeberU.1999The professional acceptance of drug use: A closer look at drug consumption rooms in the Netherlands, Germany and Switzerland. International Journal of Drug Policy, 10, 99–108.
9.
DelgadoC.2004Evaluation of needle exchange programmes. Public Health Nursing, 21 (20), 171–178.
10.
Des JarlaisD.HaganH.FriedmanS.FriedmannP.GoldbergP.FrischerM.GreenS.TunvingK.LjungbergB.WodakA.1995Maintaining low HIV seroprevalence in populations of injecting drug users. Journal of the American Medical Association, 274, 1226–1231.
11.
Drug Policy Alliance1996Integrative Drogenhilfe. Frankfurt: Drug Policy Alliance.
12.
Drug Policy Alliance1997Integrative Drogenhilfe. Frankfurt: Drug Policy Alliance.
13.
European Monitoring Centre for Drugs and Drug Addiction2005Annual report 2005: The state of the drugs problem in Europe. Lisbon: EMCDDA.
14.
GlantzL. H.MarinerW. K.1996Needle exchange programs and the law–-time for a change. American Journal of Public Health, 86, 1077–78.
15.
GoldM.GafniA.1997Needle exchange programs: An economic evaluation of a local experience. Canadian Medical Association Journal, 157 (3), 255–262.
16.
GoldsteinA.1998Clinton supports needle exchanges but not funding. Washington Post (April 21).
17.
GuydishJ.BucardoJ.1998Evaluating needle exchange: A description of client characteristics, health status, program utilization and HIV risk behavior. Substance Use and Misuse, 33 (5), 1173–1196.
18.
HedrichD.2004European report on drug consumption rooms. Lisbon: EMCDDA.
19.
Her Majesty's Stationery Office2002The government's drugs policy: Is it working? Home Affairs Committee Third Report. London, UK: HMSO.
20.
HoltgraveD. R.PinkertonS. D.1997Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. Journal of AIDS and Human Retrovirology, 16, 54–62.
21.
HurleyS.JolleyD.KaldorJ.1997Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet, 349, 1797–1800.
22.
JacobJ.1999Entstehung und Praxis eines Gesundheitsraumangebotes für Drogenkonsmierende. Abschlußbericht der einjährigen Evaluation des ‘drop-in Fixpunkt.’ Hannover, Oldenburg.
23.
KelleyM.MurphyS.LuneH.2001A cultural impact of needle exchange: The role of safer-injection mentors. Contemporary Drug Problems, 28, 485–505.
24.
KsobiechK.2003A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Education and Prevention, 15 (3), 257–268.
25.
LauferF.2001Cost-effectiveness of syringe exchange as an HIV prevention strategy. Journal of AIDS, 28 (3), 273–8.
26.
LazzariniZ.2001An analysis of ethical issues in prescribing and dispensing syringes to injection drug users. Health Matrix Cleveland, 11 (1), 85–128.
27.
LurieP.DruckerE.1997An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet, 349, 604–608.
28.
LurieP.ReingoldA.1993The public health impact of needle exchange programs in the United States and abroad. Prepared for the Centers for Disease Control and Prevention.
29.
ManssonA.2000Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scandinavian Journal of Infectious Diseases, 32 (3), 253–258.
30.
MacPhersonD.1999Comprehensive systems of care for drug users in Switzerland and Frankfurt, Germany: Report from the 10th International Conference on the Reduction of Drug Related Harm and a tour of harm reduction services in Frankfurt, Germany. Vancouver, Canada: City of Vancouver, Social Planning Department.
31.
Medically Supervised Injecting Centre (MSIC) Evaluation Committee2003Final report on the evaluation report of the Sydney medically supervised centre. Sydney: MSIC Evaluation Committee.
32.
Her Majesty's Stationery Office1998National Drug Strategy. London, UK: HMSO.
33.
PoschadelS.HögerJ.SchnitzlerJ.SchreckenbergD.2003Evaluation der arbeit der Drogenkonsumraume in der Bundesrepublik Deutschland: Endbericht im Auftrag des Bundesministeriums fur Gesundheit. Das Bundesministerium fur Gesundheit und Soziale Sicherung. Baden-Baden: Nomos-Verlags-Gesellschaft.
34.
RandersonJ.2006A mountain of anomalies. The Guardian (April 24).
35.
RuncimenR.2006The report of the independent working group on drug consumption rooms. Joseph Rowntree Foundation.
36.
StoeverH.2002Consumption rooms–-A middle ground between health and public order concerns. Journal of Drug Issues, 32, 597–606.
37.
StrangJ.FortsonR.2004Supervised fixing rooms, supervised injectable maintenance clinics–-Understanding the difference. British Medical Journal, 328 (7431), 102–103.
38.
StrathdeeS. A.2004The experts speak: Needle exchange programs and the prevention of HIV infection. AIDS Patient Care and Standards, 18 (7), 373–378.
39.
StrathdeeS. A.1997Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS, 11 (8), 59–65.
40.
Morbidity and Mortality Weekly Report2005Update: Syringe exchange programs–-United States. Morbidity and Mortality Weekly Report, 54 (27), 673–676.
41.
Van BeekI.2003The Sydney medically supervised injecting centre: A clinical model. Journal of Drug Issues, 22, 625–38.
42.
VillarrealH.FoggC.2006Syringe exchange programs and HIV prevention: If they're effective, what's the controversy ?. American Journal of Nursing, 106 (5), 58–63.
43.
WattersJ.EstiloM.ClarkG.LorvickJ.1994Syringe and needle exchange as HIV/AIDS prevention for injection drug users. Journal of the American Medical Association, 271, 115–120.
44.
WrightN. M. J.2004Supervised injecting centres. British Medical Journal, 328 (7431), 100–102.
